TELEFLEX INCORPORATED COMMON STOCK

Teleflex Completes Acquisition of Standard Bariatrics

28 Sep 2022 06:30:00 By Nasdaq GlobeNewswire

Co-Author of the Karolinska 1000 Consecutive MANTA® Vascular Closure Device Study to Present Learnings at the Transcatheter Cardiovascular Therapeutics (TCT) 2022 Conference

15 Sep 2022 06:30:00 By Nasdaq GlobeNewswire

Teleflex to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

31 Aug 2022 06:30:00 By Nasdaq GlobeNewswire

Teleflex Announces Collaboration with FundamentalVR, to Improve Training Through Virtual Reality Simulation

25 Aug 2022 06:30:00 By Nasdaq GlobeNewswire

Teleflex to Expand Its Surgical Portfolio with Differentiated Stapling Technology for Bariatric Surgery

22 Aug 2022 06:30:00 By Nasdaq GlobeNewswire

Teleflex Publishes 2021 Global Impact Report

29 Jul 2022 06:30:00 By Nasdaq GlobeNewswire

Teleflex Announces Quarterly Dividend

28 Jul 2022 06:45:00 By Nasdaq GlobeNewswire

Teleflex Reports Second Quarter Financial Results And Full Year Outlook

28 Jul 2022 06:30:00 By Nasdaq GlobeNewswire

Teleflex Announces Pocono Raceway NASCAR Event to Raise Visibility of Enlarged Prostate and the Importance of Regular Health Screenings

21 Jul 2022 06:30:00 By Nasdaq GlobeNewswire

Teleflex Announces Second Quarter 2022 Earnings Conference Call Information

14 Jul 2022 06:30:00 By Nasdaq GlobeNewswire

New Data Reinforce Efficacy of the UroLift® System for the Treatment of Enlarged Prostate

01 Jul 2022 06:30:00 By Nasdaq GlobeNewswire

Teleflex Announces First Patient Enrollment in MANTA Ultra Study

22 Jun 2022 06:30:00 By Nasdaq GlobeNewswire

Teleflex launches new Arrow Pressure Injectable Midline Catheter in Australia and New Zealand

13 Jun 2022 16:30:00 By Nasdaq GlobeNewswire

Teleflex launches new Arrow Pressure Injectable Midline Catheter in Europe, the Middle East and Africa region

07 Jun 2022 00:30:00 By Nasdaq GlobeNewswire

Teleflex Celebrates June Men’s Health Month with Launch of UroLift® Patient Ambassador Program

01 Jun 2022 06:30:00 By Nasdaq GlobeNewswire

Teleflex Hosts 2022 Analyst & Investor Day

20 May 2022 06:30:00 By Nasdaq GlobeNewswire

Teleflex Announces Regulatory Clearance for its UroLift® System in China for the Treatment of Benign Prostatic Hyperplasia (BPH)

19 May 2022 06:30:00 By Nasdaq GlobeNewswire

Teleflex Announces Health Canada Approval of MANTA® Vascular Closure Device

18 May 2022 06:30:00 By Nasdaq GlobeNewswire

Teleflex Announces Full U.S. Commercial Launch of the UroLift® 2 System and UroLift ATC ® Advanced Tissue Control System

13 May 2022 06:30:00 By Nasdaq GlobeNewswire

Teleflex to Host Analyst & Investor Day on May 20, 2022

02 May 2022 06:45:00 By Nasdaq GlobeNewswire